Blis welcomes new board member

NZX Release 3 August 2018 Blis welcomes new board member Blis Technologies Limited (NZX:BLT) welcomes Mr Barry Richardson as an independent director of the company following his election at the Annual Meeting held on Friday 27th July 2018. Mr Richardson will bring more than 30 years of management experience in commercialising science and undertaking business development roles for early stage biotechnology and nutritional companies, including his time with Tatua Co-Operative Dairy Ltd, Westland Milk Products Ltd and 10 years as CEO of Blis Technologies Ltd. Holding a PhD from Massey University and current directorships in CertusBio and CNS Biotechnology, Mr Richardson will bring valued expertise and experience to the board. Blis are the developers of the world's first advanced oral probiotics. The BLIS range includes products that support ear, nose and throat health. BLIS probiotics were discovered by Professor John Tagg while working as a researcher at the University of Otago Microbiology Department. Tony Offen Chairman Contact: 021 463 336 End CA:00321700 For:BLT Type:GENERAL Time:2018-08-03 16:01:41